Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters











Publication year range
1.
Article in English | MEDLINE | ID: mdl-38768970

ABSTRACT

Many glial biologists consider glia the neglected cells of the nervous system. Among all the glia of the central and peripheral nervous system, satellite glia may be the most often overlooked. Satellite glial cells (SGCs) are located in ganglia of the cranial nerves and the peripheral nervous system. These small cells surround the cell bodies of neurons in the trigeminal ganglia (TG), spiral ganglia, nodose and petrosal ganglia, sympathetic ganglia, and dorsal root ganglia (DRG). Essential SGC features include their intimate connections with the associated neurons, their small size, and their derivation from neural crest cells. Yet SGCs also exhibit tissue-specific properties and can change rapidly, particularly in response to injury. To illustrate the range of SGC functions, we will focus on three types: those of the spiral, sympathetic, and DRG, and consider both their shared features and those that differ based on location.

2.
J Physiol ; 2024 May 22.
Article in English | MEDLINE | ID: mdl-38778747

ABSTRACT

This paper updates and builds on a previous White Paper in this journal that some of us contributed to concerning the molecular and cellular basis of cardiac neurobiology of heart disease. Here we focus on recent findings that underpin cardiac autonomic development, novel intracellular pathways and neuroplasticity. Throughout we highlight unanswered questions and areas of controversy. Whilst some neurochemical pathways are already demonstrating prognostic viability in patients with heart failure, we also discuss the opportunity to better understand sympathetic impairment by using patient specific stem cells that provides pathophysiological contextualization to study 'disease in a dish'. Novel imaging techniques and spatial transcriptomics are also facilitating a road map for target discovery of molecular pathways that may form a therapeutic opportunity to treat cardiac dysautonomia.

3.
Front Synaptic Neurosci ; 14: 995474, 2022.
Article in English | MEDLINE | ID: mdl-36247695

ABSTRACT

The Spontaneously Hypertensive Rat (SHR) has increased sympathetic drive to the periphery that precedes and contributes to the development of high blood pressure, making it a useful model for the study of neurogenic hypertension. Comparisons to the normotensive Wistar Kyoto (WKY) rat have demonstrated altered active and intrinsic properties of SHR sympathetic neurons shortly before the onset of hypertension. Here we examine the structural and functional plasticity of postnatal SHR and WKY sympathetic neurons cultured alone or co-cultured with cardiomyocytes under conditions of limited extrinsic signaling. SHR neurons have an increased number of structural synaptic sites compared to age-matched WKY neurons, measured by the co-localization of presynaptic vesicular acetylcholine transporter and postsynaptic shank proteins. Whole cell recordings show that SHR neurons have a higher synaptic charge than WKY neurons, demonstrating that the increase in synaptic sites is associated with increased synaptic transmission. Differences in synaptic properties are not associated with altered firing rates between postnatal WKY and SHR neurons and are not influenced by interactions with target cardiomyocytes from either strain. Both SHR and WKY neurons show tonic firing patterns in our cultures, which are depleted of non-neuronal ganglionic cells and provide limited neurotrophic signaling. This suggests that the normal mature, phasic firing of sympathetic neurons requires extrinsic signaling, with potentially differential responses in the prehypertensive SHR, which have been reported to maintain tonic firing at later developmental stages. While cardiomyocytes do not drive neuronal differences in our cultures, SHR cardiomyocytes display decreased hypertrophy compared to WKY cells and altered responses to co-cultured sympathetic neurons. These experiments suggest that altered signaling in SHR neurons and cardiomyocytes contributes to changes in the cardiac-sympathetic circuit in prehypertensive rats as early as the postnatal period.

5.
PLoS One ; 15(2): e0218643, 2020.
Article in English | MEDLINE | ID: mdl-32017764

ABSTRACT

Postganglionic sympathetic neurons and satellite glial cells are the two major cell types of the peripheral sympathetic ganglia. Sympathetic neurons project to and provide neural control of peripheral organs and have been implicated in human disorders ranging from cardiovascular disease to peripheral neuropathies. Here we show that satellite glia regulate synaptic activity of cultured postnatal sympathetic neurons, providing evidence for local ganglionic control of sympathetic drive. In addition to modulating neuron-to-neuron cholinergic neurotransmission, satellite glia promote synapse formation and contribute to neuronal survival. Examination of the cellular architecture of the rat sympathetic ganglia in vivo shows this regulation of neuronal properties takes place during a developmental period in which neuronal morphology and density are actively changing and satellite glia enwrap sympathetic neuronal somata. Cultured satellite glia make and release factors that promote neuronal activity and that can partially rescue the neurons from cell death following nerve growth factor deprivation. Thus, satellite glia play an early and ongoing role within the postnatal sympathetic ganglia, expanding our understanding of the contributions of local and target-derived factors in the regulation of sympathetic neuron function.


Subject(s)
Cholinergic Neurons/metabolism , Ganglia, Sympathetic/physiology , Neuroglia/metabolism , Synaptic Transmission , Animals , Cells, Cultured , Cholinergic Neurons/physiology , Female , Ganglia, Sympathetic/cytology , Male , Neuroglia/physiology , Rats , Rats, Sprague-Dawley
6.
J Physiol ; 594(14): 3853-75, 2016 07 15.
Article in English | MEDLINE | ID: mdl-27060296

ABSTRACT

The nervous system and cardiovascular system develop in concert and are functionally interconnected in both health and disease. This white paper focuses on the cellular and molecular mechanisms that underlie neural-cardiac interactions during development, during normal physiological function in the mature system, and during pathological remodelling in cardiovascular disease. The content on each subject was contributed by experts, and we hope that this will provide a useful resource for newcomers to neurocardiology as well as aficionados.


Subject(s)
Heart Diseases/physiopathology , Heart/innervation , Heart/physiology , Animals , Heart/physiopathology , Humans , Neurotransmitter Agents/physiology , Synaptic Transmission
7.
Mol Biol Cell ; 25(6): 811-27, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24430873

ABSTRACT

Cardiac and skeletal muscle function depends on the proper formation of myofibrils, which are tandem arrays of highly organized actomyosin contractile units called sarcomeres. How the architecture of these colossal molecular assemblages is established during development and maintained over the lifetime of an animal is poorly understood. We investigate the potential roles in myofibril formation and repair of formin proteins, which are encoded by 15 different genes in mammals. Using quantitative real-time PCR analysis, we find that 13 formins are differentially expressed in mouse hearts during postnatal development. Seven formins immunolocalize to sarcomeres in diverse patterns, suggesting that they have a variety of functional roles. Using RNA interference silencing, we find that the formins mDia2, DAAM1, FMNL1, and FMNL2 are required nonredundantly for myofibrillogenesis. Knockdown phenotypes include global loss of myofibril organization and defective sarcomeric ultrastructure. Finally, our analysis reveals an unanticipated requirement specifically for FMNL1 and FMNL2 in the repair of damaged myofibrils. Together our data reveal an unexpectedly large number of formins, with diverse localization patterns and nonredundant roles, functioning in myofibril development and maintenance, and provide the first evidence of actin assembly factors being required to repair myofibrils.


Subject(s)
Intracellular Signaling Peptides and Proteins/genetics , Microfilament Proteins/genetics , Microtubule-Associated Proteins/genetics , Muscle Development/genetics , Myocardium/metabolism , NADPH Dehydrogenase/genetics , Sarcomeres/metabolism , rho GTP-Binding Proteins/genetics , Actins/genetics , Actins/metabolism , Animals , Animals, Newborn , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Cell Differentiation , Formins , Gene Expression Regulation, Developmental , Heterocyclic Compounds, 4 or More Rings/pharmacology , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/metabolism , Mice , Mice, Inbred C57BL , Microfilament Proteins/antagonists & inhibitors , Microfilament Proteins/metabolism , Microtubule-Associated Proteins/antagonists & inhibitors , Microtubule-Associated Proteins/metabolism , Myocardium/cytology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/ultrastructure , NADPH Dehydrogenase/antagonists & inhibitors , NADPH Dehydrogenase/metabolism , Primary Cell Culture , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Sarcomeres/ultrastructure , Thiazolidines/pharmacology , Wound Healing/genetics , rho GTP-Binding Proteins/antagonists & inhibitors , rho GTP-Binding Proteins/metabolism
9.
Front Syst Neurosci ; 5: 97, 2011.
Article in English | MEDLINE | ID: mdl-22144949

ABSTRACT

Acute inhibition of acetylcholine (ACh) has been shown to impair many forms of simple learning, and notably conditioned taste aversion (CTA). The most adhered-to theory that has emerged as a result of this work - that ACh increases a taste's perceived novelty, and thereby its associability - would be further strengthened by evidence showing that enhanced cholinergic function improves learning above normal levels. Experimental testing of this corollary hypothesis has been limited, however, by side-effects of pharmacological ACh agonism and by the absence of a model that achieves long-term increases in cholinergic signaling. Here, we present this further test of the ACh hypothesis, making use of mice lacking the p75 pan-neurotrophin receptor gene, which show a resultant over-abundance of cholinergic neurons in sub-regions of the basal forebrain (BF). We first demonstrate that the p75-/- abnormality directly affects portions of the CTA circuit, locating mouse gustatory cortex (GC) using a functional assay and then using immunohistochemisty to demonstrate cholinergic hyper-innervation of GC in the mutant mice - hyper-innervation that is unaccompanied by changes in cell numbers or compensatory changes in muscarinic receptor densities. We then demonstrate that both p75-/- and wild-type (WT) mice learn robust CTAs, which extinguish more slowly in the mutants. Further testing to distinguish effects on learning from alterations in memory retention demonstrate that p75-/- mice do in fact learn stronger CTAs than WT mice. These data provide novel evidence for the hypothesis linking ACh and taste learning.

10.
Auton Neurosci ; 151(1): 46-60, 2009 Nov 17.
Article in English | MEDLINE | ID: mdl-19748836

ABSTRACT

The electrical and synaptic properties of neurons are essential for determining the function of the nervous system. Thus, understanding the mechanisms that control the appropriate developmental acquisition and maintenance of these properties is a critical problem in neuroscience. A great deal of our understanding of these developmental mechanisms comes from studies of soluble growth factor signaling between cells in the peripheral nervous system. The sympathetic nervous system has provided a model for studying the role of these factors both in early development and in the establishment of mature properties. In particular, neurotrophins produced by the targets of sympathetic innervation regulate the synaptic and electrophysiological properties of postnatal sympathetic neurons. In this review we examine the role of neurotrophin signaling in the regulation of synaptic strength, neurotransmitter phenotype, voltage-gated currents and repetitive firing properties of sympathetic neurons. Together, these properties determine the level of sympathetic drive to target organs such as the heart. Changes in this sympathetic drive, which may be linked to dysfunctions in neurotrophin signaling, are associated with devastating diseases such as high blood pressure, arrhythmias and heart attack. Neurotrophins appear to play similar roles in modulating the synaptic and electrical properties of other peripheral and central neuronal systems, suggesting that information provided from studies in the sympathetic nervous system will be widely applicable for understanding the neurotrophic regulation of neuronal function in other systems.


Subject(s)
Nerve Growth Factors/physiology , Neurons/physiology , Sympathetic Nervous System/growth & development , Synaptic Transmission/physiology , Action Potentials/physiology , Adrenergic Fibers/physiology , Animals , Autonomic Nervous System Diseases/physiopathology , Cholinergic Fibers/physiology , Ganglia, Sympathetic/cytology , Ganglia, Sympathetic/physiology , Humans , Ion Channel Gating/physiology , Nerve Tissue Proteins/physiology , Neuronal Plasticity/physiology , Neurons/cytology , Phosphorylation , Potassium/physiology , Potassium Channels/physiology , Protein Processing, Post-Translational , Receptor, Nerve Growth Factor/physiology , Receptor, trkA/physiology , Sympathetic Nervous System/cytology , Sympathetic Nervous System/embryology , Sympathetic Nervous System/physiology , Synapses/physiology
11.
J Neurosci ; 29(17): 5411-24, 2009 Apr 29.
Article in English | MEDLINE | ID: mdl-19403809

ABSTRACT

Neurotrophins such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) act through the tropomyosin-related receptor tyrosine kinases (Trk) and the pan-neurotrophin receptor (p75) to regulate complex developmental and functional properties of neurons. While NGF activates both receptor types in sympathetic neurons, differential signaling through TrkA and p75 can result in widely divergent functional outputs for neuronal survival, growth, and synaptic function. Here we show that TrkA and p75 signaling pathways have opposing effects on the firing properties of sympathetic neurons, and define a mechanism whereby the relative level of signaling through these two receptors sets firing patterns via coordinate regulation of a set of ionic currents. We show that signaling through the p75 pathway causes sympathetic neurons to fire in a phasic pattern showing marked accommodation. Signaling through the NGF-specific TrkA, on the other hand, causes cells to fire tonically. Neurons switch rapidly between firing patterns, on the order of minutes to hours. We show that changes in firing patterns are caused by neurotrophin-dependent regulation of at least four voltage-gated currents: the sodium current and the M-type, delayed rectifier, and calcium-dependent potassium currents. Neurotrophin release, and thus receptor activation, varies among somatic tissues and physiological state. Thus, these data suggest that target-derived neurotrophins may be an important determinant of the characteristic electrical properties of sympathetic neurons and therefore regulate the functional output of the sympathetic nervous system.


Subject(s)
Adrenergic Fibers/physiology , Ion Channels/physiology , Neurons/physiology , Receptor, Nerve Growth Factor/physiology , Receptor, trkA/physiology , Signal Transduction/physiology , Animals , Cells, Cultured , Ion Channel Gating/physiology , Mice , Patch-Clamp Techniques , Rats
12.
Dev Neurosci ; 31(6): 473-86, 2009.
Article in English | MEDLINE | ID: mdl-19325229

ABSTRACT

A fundamental problem in developmental neuroscience is understanding how extracellular cues link to complex intracellular signaling pathways to drive stage-specific developmental decisions. During the formation of the mammalian peripheral nervous system, bone morphogenetic proteins (BMPs) promote neuronal differentiation. BMPs also maintain the expression of early glial genes such as GFAP, while blocking the acquisition of a mature, myelinating Schwann cell phenotype. We investigated the BMP-activated signaling pathways that contribute to early glial gene expression to address the question of how specific signaling interactions contribute to cell fate decisions in neural crest lineages. Using a neural-crest-derived cell line that exhibits the characteristics of immature Schwann cells, we found that BMP2 promotes GFAP expression using Smad signaling as well as the phosphoinositide-3 kinase (PI3K) and mitogen-activated protein kinase1/2extracellular signal-regulated kinase- (MEK1/2/ERK) pathways. The GFAP promoter does not contain known Smad consensus sites, suggesting that Smads may act indirectly to promote GFAP expression. We provide evidence that this indirect effect may be mediated via induction of immediate early genes and the transcription factor Sp1 by demonstrating that these transcriptional regulators are induced by BMP2 and contribute to GFAP promoter activity. These findings demonstrate new roles for intracellular kinase pathways in mediating the effects of BMPs during the early stages of glial differentiation and suggest that differential contributions by signaling and transcriptional networks may contribute to the range of effects of BMPs on neuronal and glial development during the formation of the peripheral nervous system.


Subject(s)
Astrocytes/metabolism , Bone Morphogenetic Protein 2/metabolism , Gene Expression/genetics , Glial Fibrillary Acidic Protein/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Analysis of Variance , Animals , Astrocytes/drug effects , Blotting, Western , Bone Morphogenetic Protein 2/pharmacology , Butadienes/pharmacology , Cell Line , Cells, Cultured , Chromones/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression/drug effects , Genes, Immediate-Early/genetics , Glial Fibrillary Acidic Protein/genetics , Intracellular Signaling Peptides and Proteins/genetics , Morpholines/pharmacology , Nitriles/pharmacology , Organic Chemicals/pharmacology , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Signal Transduction/genetics , Time Factors , Transfection
13.
Auton Neurosci ; 140(1-2): 40-8, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18430612

ABSTRACT

Homeostatic regulation of cardiac function is dependent on the balance of inputs from the sympathetic and parasympathetic nervous systems. We investigated whether the p75 neurotrophin receptor plays a developmental role in cardiac innervation by analyzing sympathetic and parasympathetic fibers in the atria of p75 knockout and wildtype mice at several stages of postnatal development, and examining the effect on control of heart rate. We found that parasympathetic innervation of the atria in p75-/- mice was similar to wildtype at all time points, but that the density of sympathetic innervation was dynamically regulated. Compared to wildtype mice, the p75-/- mice had less innervation at postnatal day 4, an increase at day 28, and decreased innervation in adult mice. These changes reflect defects in initial fiber in-growth and the timing of the normal developmental decrease in sympathetic innervation density in the atria. Thus, p75 regulates both the growth and stability of cardiac sympathetic fibers. The distribution of sympathetic fibers was also altered, so that many regions lacked innervation. Basal heart rate was depressed in adult p75-/- mice, and these mice exhibited a diminished heart rate response to restraint stress. This resulted from the lack of sympathetic innervation rather than increased parasympathetic transmission or a direct effect of p75 in cardiac cells. Norepinephrine was elevated in p75-/- atria, but stimulating norepinephrine release with tyramine produced less tachycardia in p75-/- mice than wild type mice. This suggests that altered density and distribution of sympathetic fibers in p75-/- atria impairs the control of heart rate.


Subject(s)
Heart/innervation , Parasympathetic Nervous System/metabolism , Receptor, Nerve Growth Factor/metabolism , Sympathetic Nervous System/metabolism , Adrenergic Uptake Inhibitors/pharmacology , Aging/physiology , Animals , Cell Differentiation/physiology , Growth Cones/metabolism , Growth Cones/ultrastructure , Heart/growth & development , Heart/physiology , Heart Atria/growth & development , Heart Atria/innervation , Heart Rate/drug effects , Heart Rate/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Growth Factor/metabolism , Neurotrophin 3/metabolism , Norepinephrine/metabolism , Parasympathetic Nervous System/cytology , Parasympathetic Nervous System/growth & development , Presynaptic Terminals/metabolism , Receptor, Nerve Growth Factor/genetics , Stress, Psychological/genetics , Stress, Psychological/metabolism , Sympathetic Nervous System/cytology , Sympathetic Nervous System/growth & development , Synaptic Transmission/genetics , Tachycardia/chemically induced , Tachycardia/metabolism , Tachycardia/physiopathology , Tyramine/pharmacology
14.
Dev Biol ; 315(2): 404-17, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-18272145

ABSTRACT

Target-derived factors modulate many aspects of peripheral neuron development including neuronal growth, survival, and maturation. Less is known about how initial target contact regulates changes in gene expression associated with these developmental processes. One early consequence of contact between growing sympathetic neurons and their cardiac myocyte targets is the inhibition of neuronal outgrowth. Analysis of neuronal gene expression following this contact revealed coordinate regulation of a bone morphogenetic protein (BMP)-dependent growth pathway in which basic helix-loop-helix transcription factors and downstream neurofilament expression contribute to the growth dynamics of developing sympathetic neurons. BMP2 had dose-dependent growth-promoting effects on sympathetic neurons cultured in the absence, but not the presence, of myocyte targets, suggesting that target contact alters neuronal responses to BMP signaling. Target contact also induced the expression of matrix Gla protein (MGP), a regulator of BMP function in the vascular system. Increased MGP expression inhibited BMP-dependent neuronal growth and MGP expression increased in sympathetic neurons during the period of target contact in vivo. These experiments establish MGP as a novel regulator of BMP function in the nervous system, and define developmental transitions in BMP responses during sympathetic development.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Neurons/metabolism , Animals , Base Sequence , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Bone Morphogenetic Proteins/genetics , Calcium-Binding Proteins/metabolism , Cell Communication , Cells, Cultured , Coculture Techniques , DNA Primers/genetics , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Extracellular Matrix Proteins/metabolism , Gene Expression Regulation, Developmental , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Neurites/metabolism , Neurites/ultrastructure , Neurofilament Proteins/genetics , Neurofilament Proteins/metabolism , Neurons/cytology , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Signal Transduction , Sympathetic Nervous System/cytology , Sympathetic Nervous System/embryology , Sympathetic Nervous System/growth & development , Sympathetic Nervous System/metabolism , Matrix Gla Protein
15.
J Neurosci ; 27(47): 12787-96, 2007 Nov 21.
Article in English | MEDLINE | ID: mdl-18032650

ABSTRACT

Basal forebrain GABAergic and cholinergic circuits regulate the activity of cholinergic projections to the cortex and hippocampus. Because these projections influence cortical development and function, the development of basal forebrain excitatory and inhibitory neurons is critical for overall brain development. We show that the neurotransmitter phenotype of these neurons is developmentally regulated by neurotrophins and the p75 receptor. Neurotrophins (nerve growth factor and brain-derived neurotrophic factor) increased the number of both cholinergic and GABAergic neurons in neonatal basal forebrain neuron cultures from the region of the medial septum. However, the p75 receptor is required only for neurotrophin-dependent expansion of the GABAergic, not the cholinergic, population. Neurotrophin-induced GABAergic development can be rescued in p75-/- cultures by expression of a p75 rescue construct in neighboring cells or by treatment with medium collected from neurotrophin-treated wild-type cultures. Because p75 is not expressed in basal forebrain GABAergic neurons, this defines a new, non-cell-autonomous mechanism of p75 action in which ligand binding results in release of a soluble factor that modifies neurotrophin responses of nearby neurons. p75 is also required for the maintenance of basal forebrain GABAergic neurons in vivo, demonstrating that p75-mediated interactions between cholinergic and GABAergic neurons regulate the balance of excitatory and inhibitory components of basal forebrain circuits.


Subject(s)
Cell Differentiation/physiology , Nerve Growth Factors/pharmacology , Neurons/physiology , Receptor, Nerve Growth Factor/physiology , gamma-Aminobutyric Acid/physiology , Animals , Animals, Newborn , Cell Death/physiology , Cell Proliferation , Cells, Cultured , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Growth Factors/physiology , Neural Inhibition/physiology , Neurons/cytology , Prosencephalon/growth & development , Prosencephalon/metabolism , Receptor, Nerve Growth Factor/deficiency , Receptor, Nerve Growth Factor/genetics
16.
J Neurophysiol ; 96(2): 946-58, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16707716

ABSTRACT

The sympathetic nervous system is an essential regulator of the cardiovascular system and interactions with target tissue regulate sympathetic neuronal properties. The heart produces nerve growth factor (NGF), which promotes sympathetic noradrenergic innervation of cardiac tissue and affects sympathetic synaptic strength. Neurotrophins, including NGF, are important modulators of synaptic plasticity and membrane electrical properties. Here we show that acute application of NGF causes a change in the repetitive firing pattern of cultured sympathetic neurons of the rat superior cervical ganglion. Neurons fire fewer action potentials in NGF, but with increased frequency, demonstrating an NGF-dependent change from a tonic to a phasic firing pattern. Additionally, NGF decreases the spike time variance, making spikes more tightly time locked to stimulus onset. NGF causes a decrease in the amplitude of both calcium-dependent and -independent potassium currents, and inhibition of calcium-dependent potassium currents using CdCl(2) reproduces some, but not all, of the firing properties induced by NGF. This study suggests that NGF release from cardiac tissue may act to modulate the repetitive firing properties of sympathetic neurons to tune their output to meet the physiological needs of the organism.


Subject(s)
Nerve Growth Factors/pharmacology , Neurons/physiology , Potassium Channels/drug effects , Sympathetic Nervous System/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Calcium Channels/drug effects , Calcium Channels/physiology , Cells, Cultured , Data Interpretation, Statistical , Electric Stimulation , Electrophysiology , Heart/innervation , Heart/physiology , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Neural Conduction/drug effects , Patch-Clamp Techniques , Potassium Channels/physiology , Rats , Superior Cervical Ganglion/cytology , Superior Cervical Ganglion/physiology , Sympathetic Nervous System/cytology
17.
Proc Natl Acad Sci U S A ; 103(8): 2915-9, 2006 Feb 21.
Article in English | MEDLINE | ID: mdl-16476997

ABSTRACT

Neurotrophins regulate sympathetic neuron cotransmission by modulating the activity-dependent release of norepinephrine and acetylcholine. Nerve growth factor promotes excitatory noradrenergic transmission, whereas brain-derived neurotrophic factor (BDNF), acting through the p75 receptor, increases inhibitory cholinergic transmission. This regulation of corelease by target-derived factors leads to the functional modulation of myocyte beat rate in neuron-myocyte cocultures. Calcium/calmodulin-dependent protein kinase II (CaMKII) has been implicated in the control of both pre- and postsynaptic mechanisms of synaptic plasticity. We demonstrate that CaMKII acts in conjunction with p75 signaling to regulate cholinergic transmission between sympathetic neurons and heart cells. Inhibition of presynaptic CaMKII prevents the BDNF-dependent shift to inhibitory neurotransmission, whereas presynaptic expression of a constitutively active CaMKII results in inhibitory neurotransmission in the absence of added BDNF, suggesting that activation of presynaptic CaMKII is both necessary and sufficient for a shift from excitatory to inhibitory transmission. Several isozymes of CaMKII are expressed in sympathetic neurons, with the delta-CaMKII being activated by BDNF and nerve growth factor. Activated CaMKII is less effective at promoting cholinergic transmission in the absence of p75 signaling, demonstrating that p75 and CaMKII act to coordinate neurotransmitter selection in sympathetic neurons.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/physiology , Receptor, Nerve Growth Factor/physiology , Sympathetic Nervous System/physiology , Synaptic Transmission , Animals , Brain-Derived Neurotrophic Factor/pharmacology , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cells, Cultured , Enzyme Activation , Mice , Nerve Growth Factors/pharmacology , Neurons/physiology , Rats , Receptor, Nerve Growth Factor/agonists , Sympathetic Nervous System/metabolism
18.
Dev Neurosci ; 27(1): 37-48, 2005.
Article in English | MEDLINE | ID: mdl-15886483

ABSTRACT

Bone morphogenetic proteins (BMPs) regulate developmental decisions in many neural and nonneural lineages. BMPs influence both CNS neuronal and glial development and promote neuronal differentiation in neural crest derivatives. We investigated the actions of BMP2 on glial differentiation in the peripheral nervous system using NCM1 cells, a neural crest-derived cell line with the properties of peripheral glial precursor cells. BMP2 prevented the acquisition of a mature Schwann cell-like morphology, blocking the expression of mature genes and maintaining expression of several early glial markers. We provide evidence that BMP2 activates the GFAP promoter and define signaling pathways underlying this regulation. Our results demonstrate a novel role for BMPs as inhibitors of glial differentiation in the peripheral nervous system and suggest that BMPs may regulate the developmental timing of glial maturation.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cell Differentiation/drug effects , Growth Inhibitors/pharmacology , Neural Crest/embryology , Neuroglia/drug effects , Peripheral Nervous System/embryology , Transforming Growth Factor beta/pharmacology , Animals , Biomarkers/metabolism , Bone Morphogenetic Protein 2 , Cell Differentiation/physiology , Cell Line, Transformed , Cell Shape/drug effects , Cell Shape/physiology , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Glial Fibrillary Acidic Protein/genetics , Neural Crest/cytology , Neural Crest/metabolism , Neuroglia/cytology , Neuroglia/metabolism , Peripheral Nervous System/cytology , Peripheral Nervous System/metabolism , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , Rats , Schwann Cells/cytology , Schwann Cells/drug effects , Schwann Cells/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology , Stem Cells/cytology , Stem Cells/drug effects , Stem Cells/metabolism
19.
Mol Cell Neurosci ; 23(4): 648-60, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12932444

ABSTRACT

Cultured neonatal sympathetic neurons can synthesize and corelease norepinephrine (NE) and acetylcholine (ACh). Evoked release of NE has an excitatory effect on the beat rate of cocultured cardiac myocytes while ACh release results in myocyte inhibition. Here we show that the cholinergic properties of the neurons and the relative level of NE and ACh corelease are modulated by neurotrophic factors. Brain-derived neurotrophic factor (BDNF) rapidly promoted ACh release in the absence of cholinergic differentiation activity and even in neurons that were predominantly noradrenergic. This increase in the cholinergic component of sympathetic cotransmission was sufficient for myocytes to display an overall inhibitory response to neuronal stimulation. In contrast, short-term growth in ciliary neurotrophic factor (CNTF) resulted in the upregulation of cholinergic and downregulation of noradrenergic markers without an effect on normal excitatory neurotransmission. Only once the cells had acquired a cholinergic phenotype did CNTF acutely promote the evoked release of the cholinergic vesicle pool. The results of this study indicate that BDNF and CNTF, acting through independent pathways, modulate NE and ACh cotransmission to regulate the level of sympathetic excitation or inhibition of cardiac myocytes.


Subject(s)
Acetylcholine/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Cell Differentiation/physiology , Ciliary Neurotrophic Factor/metabolism , Ganglia, Sympathetic/metabolism , Neurons/metabolism , Animals , Animals, Newborn , Brain-Derived Neurotrophic Factor/pharmacology , Cell Differentiation/drug effects , Cells, Cultured , Choline O-Acetyltransferase/genetics , Ciliary Neurotrophic Factor/pharmacology , Coculture Techniques , Down-Regulation/drug effects , Down-Regulation/physiology , Ganglia, Sympathetic/drug effects , Ganglia, Sympathetic/growth & development , Mice , Mice, Knockout , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/drug effects , Norepinephrine/metabolism , Norepinephrine Plasma Membrane Transport Proteins , Phenotype , RNA, Messenger/metabolism , Rats , Symporters/genetics , Tyrosine 3-Monooxygenase/genetics , Up-Regulation/drug effects , Up-Regulation/physiology
20.
Nat Neurosci ; 5(6): 539-45, 2002 Jun.
Article in English | MEDLINE | ID: mdl-11992117

ABSTRACT

Cardiac function is modulated by norepinephrine release from innervating sympathetic neurons. These neurons also form excitatory connections onto cardiac myocytes in culture. Here we report that brain-derived neurotrophic factor (BDNF) altered the neurotransmitter release properties of these sympathetic neuron-myocyte connections in rodent cell culture, leading to a rapid shift from excitatory to inhibitory cholinergic transmission in response to neuronal stimulation. Fifteen minutes of BDNF perfusion was sufficient to cause this shift to inhibitory transmission, indicating that BDNF promotes preferential release of acetylcholine in response to neuronal stimulation. We found that p75(-/-) neurons did not release acetylcholine in response to BDNF and that neurons overexpressing p75 showed increased cholinergic transmission, indicating that the actions of BDNF are mediated through the p75 neurotrophin receptor. Our findings indicate that p75 is involved in modulating the release of distinct neurotransmitter pools, resulting in a functional switch between excitatory and inhibitory neurotransmission in individual neurons.


Subject(s)
Neurotransmitter Agents/metabolism , Receptors, Nerve Growth Factor/physiology , Sympathetic Nervous System/metabolism , Acetylcholine/metabolism , Animals , Brain-Derived Neurotrophic Factor/pharmacology , Cell Communication/physiology , Cells, Cultured , Cholinergic Fibers/drug effects , Cholinergic Fibers/physiology , Coculture Techniques , Mice , Mice, Knockout/genetics , Myocardium/cytology , Neurons/metabolism , Neurons/physiology , Presynaptic Terminals/drug effects , Rats , Receptor, Nerve Growth Factor , Receptors, Nerve Growth Factor/genetics , Sympathetic Nervous System/cytology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL